Inventor · disambiguated record
Ellen Laird
Also filed as: LAIRD ELLEN · LAIRD ELLEN R · LAIRD ELLEN RUTH
36 granted patents·17 pending applications·367 citations·filing 1997–2025
97Inventor score
Top patents by PatentIndex Score
53 records- 0196US7449486B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Nov 11, 2008·37 cites·34 claims
- 0295US6696464B2Triazolo-pyridines anti-inflammatory compoundsPFIZER·Filed 2002·Granted Feb 24, 2004·91 cites·53 claims
- 0394US11414404B2Compounds for the treatment of BRAF-associated diseases and disordersARRAY BIOPHARMA INC·Filed 2020·Granted Aug 16, 2022·5 cites·14 claims
- 0492US7732446B1Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2005·Granted Jun 8, 2010·15 cites·25 claims
- 0590US7491829B2RAF inhibitor compounds and methodsARRAY BIOPHARMA INC·Filed 2006·Granted Feb 17, 2009·17 cites·49 claims
- 0689US10730880B24,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·25 claims
- 0789US7795282B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 14, 2010·9 cites·2 claims
- 0888US11780835B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2021·Granted Oct 10, 2023·1 cites·9 claims
- 0988US7956073B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Jun 7, 2011·8 cites·11 claims
- 1087US9221841B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Dec 29, 2015·5 cites·19 claims
- 1187US8236825B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2011·Granted Aug 7, 2012·7 cites·24 claims
- 1286US6114361A5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivativesPFIZER·Filed 1999·Granted Sep 5, 2000·71 cites·19 claims
- 1385US8268871B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2010·Granted Sep 18, 2012·7 cites·10 claims
- 1484US11104676B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2019·Granted Aug 31, 2021·1 cites·4 claims
- 1583US8623895B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2012·Granted Jan 7, 2014·4 cites·104 claims
- 1683US8044083B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Oct 25, 2011·5 cites·12 claims
- 1782US9102639B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2013·Granted Aug 11, 2015·3 cites·22 claims
- 1882US8580828B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2012·Granted Nov 12, 2013·5 cites·35 claims
- 1979US8039639B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Granted Oct 18, 2011·4 cites·1 claims
- 2079US6664395B2Benzotriazoles anti-inflammatory compoundsPFIZER·Filed 2002·Granted Dec 16, 2003·13 cites·50 claims
- 2178US10189845B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jan 29, 2019·2 cites·20 claims
- 2278US2024174666A1PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASESARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2377US8394795B2Pyrazole [3, 4-B] pyridine Raf inhibitorsAHRENDT KATERI A·Filed 2009·Granted Mar 12, 2013·5 cites·45 claims
- 2476US8338452B2Raf inhibitor compounds and methods of use thereofAHRENDT KATERI A·Filed 2009·Granted Dec 25, 2012·4 cites·49 claims
- 2575US11247990B1Bicyclic fused pyridine compounds as inhibitors of TAM kinasesARRAY BIOPHARMA INC·Filed 2018·Granted Feb 15, 2022·1 cites·20 claims
- 2674US9499503B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Nov 22, 2016·1 cites·18 claims
- 2772US7351825B2Cyclopropane compounds and pharmaceutical use thereofJAPAN TOBACCO INC·Filed 2004·Granted Apr 1, 2008·9 cites·33 claims
- 2871US11634409B2Compounds for the treatment of BRAF-associated diseases and disordersARRAY BIOPHARMA INC·Filed 2022·Granted Apr 25, 2023·0 cites·42 claims
- 2970US2024124474A1Her2 mutation inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3069US6458822B22-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinasesPFIZER·Filed 2000·Granted Oct 1, 2002·3 cites·27 claims
- 3168US12303509B2Compounds for the treatment of BRAF-associated diseases and disordersPFIZER·Filed 2021·Granted May 20, 2025·0 cites·16 claims
- 3267US11834453B2Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitorsARRAY BIOPHARMA INC·Filed 2021·Granted Dec 5, 2023·0 cites·28 claims
- 3367US6251620B1Three dimensional structure of a ZAP tyrosine protein kinase fragment and modeling methodsARIAD PHARMA INC·Filed 1997·Granted Jun 26, 2001·30 cites·7 claims
- 3467US2018334441A1Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 3564US11028093B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Jun 8, 2021·0 cites·19 claims
- 3663US10017482B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 3762US2025241915A1Compounds for the treatment of braf-associated diseases and disordersPFIZER·Filed 2025·Application pending·0 cites
- 3861US2014018399A1Mitotic kinesin inhibtors and methods of use thereofARRAY BIOPHARMA INC·Filed 2013·Application pending·0 cites
- 3961US2010105894A1Cyclopropane compounds and pharmaceutical use thereofJAPAN TOBACCO INC·Filed 2009·Application pending·0 cites
- 4057US2008306258A1Cyclopropane compounds and pharmaceutical use thereofJAPAN TOBACCO INC·Filed 2008·Application pending·0 cites
- 4157US2009176809A1Raf inhibitor compounds and methodsLAIRD ELLEN·Filed 2008·Application pending·0 cites
- 4256US2008261994A1Cyclopropane compounds and pharmaceutical use thereofJAPAN TOBACCO INC·Filed 2008·Application pending·0 cites
- 4354US12447153B2HER2 mutation inhibitorsARRAY BIOPHARMA INC·Filed 2022·Granted Oct 21, 2025·0 cites·18 claims
- 4450US2008242656A1N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use ThereofJAPAN TOBACCO INC·Filed 2007·Application pending·0 cites
- 4548US2002147224A12-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinasesFiled 2002·Application pending·0 cites
- 4648US2005222146A1N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereofFRYER ANDREW M·Filed 2004·Application pending·0 cites
- 4743US7566716B2Imidazopyrazines as Raf inhibitor compoundsARRAY BIOPHARMA INC·Filed 2006·Granted Jul 28, 2009·0 cites·21 claims
- 4843US2007049603A1Raf inhibitor compounds and methods of use thereofMIKNIS GREG·Filed 2006·Application pending·0 cites
- 4941US2014228349A15,7-substituted-imidazo[1,2-c]pyrimidinesARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 5038US2013018033A1Raf inhibitor compounds and methods of use thereofARRAY BIOPHARMA INC·Filed 2010·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ellen Laird files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →